Health securityHumansUnited StatesMedical CountermeasuresUnited States Food and Drug AdministrationGovernment Regulation
Regulatory Approval of CBRN Medical Countermeasures: Current Scenario and Way Ahead.
Manan Grover, Mansi Sharma, Vikesh Kumar Shukla, Sudeep Ranjan Nayak, Navneet Sharma
Published: 202510.1177/23265094251396057
Abstract
This review is focused on chemical, biological, radiological and nuclear (CBRN) medical countermeasures (MCMs) regulations in the United States between 2014 and 2024. Primary agencies involved in this process include the Food and Drug Administration…
Preview only. Read the full abstract at the source